Drugs in Development
All Data
Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE
Lead Product(s): Sildenafil Citrate
Therapeutic Area: Endocrinology Product Name: CUREfilm Blue
Highest Development Status: IND Enabling Product Type: Small molecule
Partner/Sponsor/Collaborator: Axiom Capital Management
Deal Size: $10.0 million Upfront Cash: $4.0 million
Deal Type: Financing November 02, 2020
Details:
Funds will support the branding & product launch of Cure’s consumer products by newly acquired Sera Labs and the advancement of CURE’s clinical pharmaceutical pipeline
Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE
Lead Product(s): PRV-101
Therapeutic Area: Endocrinology Product Name: Undisclosed
Highest Development Status: IND Enabling Product Type: Vaccine
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable May 18, 2020
Details:
Publication results demonstrates that a preclinical prototype of Provention's polyvalent coxsackievirus B (CVB) vaccine, PRV-101, is well-tolerated, immunogenic and highly protective in relevant animal models.
Market Place
Active Pharmaceutical Ingredients
Finished Drug Formulations
Price
Excipients
Services
Marketplace
